Skip to Main content Skip to Navigation
Journal articles

Decreased tryptophan and increased kynurenine levels in mastocytosis associated with digestive symptoms.

Abstract : The main metabolism pathway of tryptophan is protein formation, but it can also be metabolized into serotonin and kynurenine. Indoleamine 2,3-dioxygenase (IDO) is the enzyme that catalyzes the degradation of tryptophan into kynurenine. Mastocytosis is a heterogeneous disease characterized by mast cell accumulation in various tissues with 57% of patients having gastrointestinal involvement. We studied tryptophan metabolism in mastocytosis patients displaying or not gastrointestinal features and healthy subjects (n = 26 in each group). Mastocytosis patients with digestive symptoms displayed significantly increased kynurenine level and IDO activity as compared to healthy controls and mastocytosis patients without digestive symptoms. This could be linked to mast cell-mediated digestive inflammation among patients with mastocytosis. This work is the first focusing on kynurenine pathway in a mast cell disease and could help to understand the pathogenesis of digestive features in mastocytosis as well as in other mast cell-mediated diseases.
Document type :
Journal articles
Complete list of metadatas

Cited literature [22 references]  Display  Hide  Download

https://hal.archives-ouvertes.fr/hal-01269697
Contributor : Nicolas Perron <>
Submitted on : Wednesday, March 23, 2016 - 4:15:31 PM
Last modification on : Friday, December 11, 2020 - 3:32:01 PM
Long-term archiving on: : Friday, June 24, 2016 - 1:24:39 PM

File

Georgin-Lavialle_2016_Decrease...
Files produced by the author(s)

Identifiers

Citation

Sophie Georgin-Lavialle, Jean-Marie Launay, Francine Côté, Erinn Soucié, Angèle Soria, et al.. Decreased tryptophan and increased kynurenine levels in mastocytosis associated with digestive symptoms.. Allergy, Wiley, 2016, 71 (3), pp.416-420. ⟨10.1111/all.12802⟩. ⟨hal-01269697⟩

Share

Metrics

Record views

1226

Files downloads

2415